ID   CERK1_HUMAN             Reviewed;         537 AA.
AC   Q8TCT0; A0JNT4; A8K611; Q6NX59; Q9BYB3; Q9UGE5;
DT   23-APR-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2002, sequence version 1.
DT   10-MAY-2017, entry version 135.
DE   RecName: Full=Ceramide kinase;
DE            Short=hCERK;
DE            EC=2.7.1.138;
DE   AltName: Full=Acylsphingosine kinase;
DE   AltName: Full=Lipid kinase 4;
DE            Short=LK4;
GN   Name=CERK; Synonyms=KIAA1646;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHARACTERIZATION.
RC   TISSUE=Leukemia;
RX   PubMed=11956206; DOI=10.1074/jbc.M201535200;
RA   Sugiura M., Kono K., Liu H., Shimizugawa T., Minekura H., Spiegel S.,
RA   Kohama T.;
RT   "Ceramide kinase, a novel lipid kinase. Molecular cloning and
RT   functional characterization.";
RL   J. Biol. Chem. 277:23294-23300(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Van Veldhoven P.P.;
RT   "A search for lipid kinases.";
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M.,
RA   Clamp M., Smink L.J., Ainscough R., Almeida J.P., Babbage A.K.,
RA   Bagguley C., Bailey J., Barlow K.F., Bates K.N., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Buck D., Burgess J.,
RA   Burrill W.D., Burton J., Carder C., Carter N.P., Chen Y., Clark G.,
RA   Clegg S.M., Cobley V.E., Cole C.G., Collier R.E., Connor R.,
RA   Conroy D., Corby N.R., Coville G.J., Cox A.V., Davis J., Dawson E.,
RA   Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M., Ellington A.G.,
RA   Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S.,
RA   Hunt S.E., Jones M.C., Kershaw J., Kimberley A.M., King A.,
RA   Laird G.K., Langford C.F., Leversha M.A., Lloyd C., Lloyd D.M.,
RA   Martyn I.D., Mashreghi-Mohammadi M., Matthews L.H., Mccann O.T.,
RA   Mcclay J., Mclaren S., McMurray A.A., Milne S.A., Mortimore B.J.,
RA   Odell C.N., Pavitt R., Pearce A.V., Pearson D., Phillimore B.J.C.T.,
RA   Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y., Rogers L., Ross M.T.,
RA   Scott C.E., Sehra H.K., Skuce C.D., Smalley S., Smith M.L.,
RA   Soderlund C., Spragon L., Steward C.A., Sulston J.E., Swann R.M.,
RA   Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J.,
RA   Shintani A., Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S.,
RA   Roe B.A., Chen F., Chu L., Crabtree J., Deschamps S., Do A., Do T.,
RA   Dorman A., Fang F., Fu Y., Hu P., Hua A., Kenton S., Lai H., Lao H.I.,
RA   Lewis J., Lewis S., Lin S.-P., Loh P., Malaj E., Nguyen T., Pan H.,
RA   Phan S., Qi S., Qian Y., Ray L., Ren Q., Shaull S., Sloan D., Song L.,
RA   Wang Q., Wang Y., Wang Z., White J., Willingham D., Wu H., Yao Z.,
RA   Zhan M., Zhang G., Chissoe S., Murray J., Miller N., Minx P.,
RA   Fulton R., Johnson D., Bemis G., Bentley D., Bradshaw H., Bourne S.,
RA   Cordes M., Du Z., Fulton L., Goela D., Graves T., Hawkins J.,
RA   Hinds K., Kemp K., Latreille P., Layman D., Ozersky P., Rohlfing T.,
RA   Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K., Nelson J.,
RA   Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S.,
RA   Budarf M.L., McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E.,
RA   Edelmann L., Kim U.J., Shizuya H., Simon M.I., Dumanski J.P.,
RA   Peyrard M., Kedra D., Seroussi E., Fransson I., Tapia I., Bruder C.E.,
RA   O'Brien K.P., Wilkinson P., Bodenteich A., Hartman K., Hu X.,
RA   Khan A.S., Lane L., Tilahun Y., Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 57-537 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=11258795; DOI=10.1093/dnares/8.1.1;
RA   Hirosawa M., Nagase T., Murahashi Y., Kikuno R., Ohara O.;
RT   "Identification of novel transcribed sequences on human chromosome 22
RT   by expressed sequence tag mapping.";
RL   DNA Res. 8:1-9(2001).
RN   [9]
RP   MUTAGENESIS OF LEU-10.
RX   PubMed=16081073; DOI=10.1016/j.febslet.2005.06.079;
RA   Kim T.J., Mitsutake S., Kato M., Igarashi Y.;
RT   "The leucine 10 residue in the pleckstrin homology domain of ceramide
RT   kinase is crucial for its catalytic activity.";
RL   FEBS Lett. 579:4383-4388(2005).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, ENZYME REGULATION, AND REGION.
RX   PubMed=19168031; DOI=10.1016/j.bbrc.2009.01.075;
RA   Don A.S., Rosen H.;
RT   "A lipid binding domain in sphingosine kinase 2.";
RL   Biochem. Biophys. Res. Commun. 380:87-92(2009).
RN   [11]
RP   PHOSPHORYLATION AT SER-340 AND SER-408, AND MUTAGENESIS OF SER-340.
RX   PubMed=19899769; DOI=10.1021/pr900763z;
RA   Chen W.Q., Graf C., Zimmel D., Rovina P., Krapfenbauer K., Jaritz M.,
RA   Parker P.J., Lubec G., Bornancin F.;
RT   "Ceramide kinase profiling by mass spectrometry reveals a conserved
RT   phosphorylation pattern downstream of the catalytic site.";
RL   J. Proteome Res. 9:420-429(2010).
CC   -!- FUNCTION: Catalyzes specifically the phosphorylation of ceramide
CC       to form ceramide 1-phosphate. Acts efficiently on natural and
CC       analog ceramides (C6, C8, C16 ceramides, and C8-dihydroceramide),
CC       to a lesser extent on C2-ceramide and C6-dihydroceramide, but not
CC       on other lipids, such as various sphingosines. Binds
CC       phosphoinositides. {ECO:0000269|PubMed:19168031}.
CC   -!- CATALYTIC ACTIVITY: ATP + ceramide = ADP + ceramide 1-phosphate.
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- ENZYME REGULATION: Inhibited by sulfatide.
CC       {ECO:0000269|PubMed:19168031}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 6.0-7.5.;
CC   -!- INTERACTION:
CC       P13196:ALAS1; NbExp=3; IntAct=EBI-10274247, EBI-3905054;
CC       Q5JR59:MTUS2; NbExp=3; IntAct=EBI-10274247, EBI-742948;
CC       Q7Z3S9:NOTCH2NL; NbExp=5; IntAct=EBI-10274247, EBI-945833;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:19168031}.
CC       Membrane {ECO:0000269|PubMed:19168031}; Peripheral membrane
CC       protein {ECO:0000269|PubMed:19168031}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8TCT0-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8TCT0-2; Sequence=VSP_056944;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: High level expression in heart, brain,
CC       skeletal muscle, kidney and liver; moderate in peripheral blood
CC       leukocytes and thymus; very low in spleen, small intestine,
CC       placenta and lung.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB079066; BAC01154.1; -; mRNA.
DR   EMBL; AJ457828; CAD29884.1; -; mRNA.
DR   EMBL; CR456404; CAG30290.1; -; mRNA.
DR   EMBL; AK291476; BAF84165.1; -; mRNA.
DR   EMBL; AL096766; CAI18819.1; -; Genomic_DNA.
DR   EMBL; AL118516; CAI18819.1; JOINED; Genomic_DNA.
DR   EMBL; AL118516; CAI17953.1; -; Genomic_DNA.
DR   EMBL; AL096766; CAI17953.1; JOINED; Genomic_DNA.
DR   EMBL; CH471138; EAW73440.1; -; Genomic_DNA.
DR   EMBL; CH471138; EAW73442.1; -; Genomic_DNA.
DR   EMBL; BC067255; AAH67255.1; -; mRNA.
DR   EMBL; BC126940; AAI26941.1; -; mRNA.
DR   EMBL; AB051433; BAB33316.1; -; mRNA.
DR   CCDS; CCDS14077.1; -. [Q8TCT0-1]
DR   RefSeq; NP_073603.2; NM_022766.5. [Q8TCT0-1]
DR   UniGene; Hs.200668; -.
DR   ProteinModelPortal; Q8TCT0; -.
DR   BioGrid; 122291; 45.
DR   IntAct; Q8TCT0; 46.
DR   STRING; 9606.ENSP00000216264; -.
DR   BindingDB; Q8TCT0; -.
DR   ChEMBL; CHEMBL1764936; -.
DR   GuidetoPHARMACOLOGY; 2473; -.
DR   SwissLipids; SLP:000001354; -.
DR   iPTMnet; Q8TCT0; -.
DR   PhosphoSitePlus; Q8TCT0; -.
DR   BioMuta; CERK; -.
DR   DMDM; 30172885; -.
DR   EPD; Q8TCT0; -.
DR   MaxQB; Q8TCT0; -.
DR   PaxDb; Q8TCT0; -.
DR   PeptideAtlas; Q8TCT0; -.
DR   PRIDE; Q8TCT0; -.
DR   DNASU; 64781; -.
DR   Ensembl; ENST00000216264; ENSP00000216264; ENSG00000100422. [Q8TCT0-1]
DR   GeneID; 64781; -.
DR   KEGG; hsa:64781; -.
DR   UCSC; uc003bia.4; human. [Q8TCT0-1]
DR   CTD; 64781; -.
DR   DisGeNET; 64781; -.
DR   GeneCards; CERK; -.
DR   HGNC; HGNC:19256; CERK.
DR   HPA; HPA064699; -.
DR   MIM; 610307; gene.
DR   neXtProt; NX_Q8TCT0; -.
DR   OpenTargets; ENSG00000100422; -.
DR   PharmGKB; PA134958321; -.
DR   eggNOG; KOG1115; Eukaryota.
DR   eggNOG; COG1597; LUCA.
DR   GeneTree; ENSGT00690000101761; -.
DR   HOGENOM; HOG000111551; -.
DR   HOVERGEN; HBG050903; -.
DR   InParanoid; Q8TCT0; -.
DR   KO; K04715; -.
DR   OMA; NYAMRLS; -.
DR   OrthoDB; EOG091G0FFW; -.
DR   PhylomeDB; Q8TCT0; -.
DR   TreeFam; TF314514; -.
DR   BRENDA; 2.7.1.138; 2681.
DR   Reactome; R-HSA-1660662; Glycosphingolipid metabolism.
DR   SABIO-RK; Q8TCT0; -.
DR   ChiTaRS; CERK; human.
DR   GeneWiki; CERK; -.
DR   GenomeRNAi; 64781; -.
DR   PRO; PR:Q8TCT0; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   Bgee; ENSG00000100422; -.
DR   CleanEx; HS_CERK; -.
DR   ExpressionAtlas; Q8TCT0; baseline and differential.
DR   Genevisible; Q8TCT0; HS.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0001729; F:ceramide kinase activity; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0003951; F:NAD+ kinase activity; IEA:InterPro.
DR   GO; GO:0006672; P:ceramide metabolic process; IDA:UniProtKB.
DR   GO; GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome.
DR   Gene3D; 3.40.50.10330; -; 1.
DR   InterPro; IPR017438; ATP-NAD_kinase_dom_1.
DR   InterPro; IPR001206; Diacylglycerol_kinase_cat_dom.
DR   InterPro; IPR016064; NAD/diacylglycerol_kinase.
DR   Pfam; PF00781; DAGK_cat; 1.
DR   SMART; SM00046; DAGKc; 1.
DR   SUPFAM; SSF111331; SSF111331; 3.
DR   PROSITE; PS50146; DAGK; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Calcium; Complete proteome;
KW   Cytoplasm; Kinase; Magnesium; Membrane; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transferase.
FT   CHAIN         1    537       Ceramide kinase.
FT                                /FTId=PRO_0000181354.
FT   DOMAIN      128    278       DAGKc. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00783}.
FT   NP_BIND     138    140       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00783}.
FT   NP_BIND     170    174       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00783}.
FT   NP_BIND     239    241       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00783}.
FT   NP_BIND     502    504       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00783}.
FT   REGION        1    125       Required for binding to sulfatide and
FT                                phosphoinositides.
FT   REGION      195    198       Substrate binding. {ECO:0000250}.
FT   ACT_SITE    197    197       Proton donor/acceptor. {ECO:0000250}.
FT   BINDING     202    202       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00783}.
FT   BINDING     304    304       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00783}.
FT   BINDING     310    310       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00783}.
FT   MOD_RES     340    340       Phosphoserine.
FT                                {ECO:0000269|PubMed:19899769}.
FT   MOD_RES     408    408       Phosphoserine.
FT                                {ECO:0000269|PubMed:19899769}.
FT   VAR_SEQ       1    198       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_056944.
FT   VARIANT     191    191       I -> V (in dbSNP:rs16995615).
FT                                /FTId=VAR_053685.
FT   VARIANT     211    211       T -> M (in dbSNP:rs9306515).
FT                                /FTId=VAR_053686.
FT   VARIANT     306    306       L -> F (in dbSNP:rs13057352).
FT                                /FTId=VAR_053687.
FT   MUTAGEN      10     10       L->A: 99% decrease in catalytic activity
FT                                but no effect on substrate affinity.
FT                                {ECO:0000269|PubMed:16081073}.
FT   MUTAGEN      10     10       L->I: 71% decrease in catalytic activity
FT                                but no effect on substrate affinity.
FT                                {ECO:0000269|PubMed:16081073}.
FT   MUTAGEN     340    340       S->A: 15% decrease in catalytic activity
FT                                and decreased stability.
FT                                {ECO:0000269|PubMed:19899769}.
SQ   SEQUENCE   537 AA;  59977 MW;  3DBFC0ED8D679F7F CRC64;
     MGATGAAEPL QSVLWVKQQR CAVSLEPARA LLRWWRSPGP GAGAPGADAC SVPVSEIIAV
     EETDVHGKHQ GSGKWQKMEK PYAFTVHCVK RARRHRWKWA QVTFWCPEEQ LCHLWLQTLR
     EMLEKLTSRP KHLLVFINPF GGKGQGKRIY ERKVAPLFTL ASITTDIIVT EHANQAKETL
     YEINIDKYDG IVCVGGDGMF SEVLHGLIGR TQRSAGVDQN HPRAVLVPSS LRIGIIPAGS
     TDCVCYSTVG TSDAETSALH IVVGDSLAMD VSSVHHNSTL LRYSVSLLGY GFYGDIIKDS
     EKKRWLGLAR YDFSGLKTFL SHHCYEGTVS FLPAQHTVGS PRDRKPCRAG CFVCRQSKQQ
     LEEEQKKALY GLEAAEDVEE WQVVCGKFLA INATNMSCAC RRSPRGLSPA AHLGDGSSDL
     ILIRKCSRFN FLRFLIRHTN QQDQFDFTFV EVYRVKKFQF TSKHMEDEDS DLKEGGKKRF
     GHICSSHPSC CCTVSNSSWN CDGEVLHSPA IEVRVHCQLV RLFARGIEEN PKPDSHS
//
